Recent advancements in medical science have opened new avenues for treating chronic diseases. A group of Chinese scientists has reportedly cured a 25-year-old woman with type 1 diabetes through a groundbreaking cell transplant procedure. This case, claimed to be the first of its kind globally, marks a significant milestone in diabetes treatment and may offer… Read More »
FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell… Read More »
Right on the heels of not one, but two CAR-T approvals in the U.S., Bristol Myers Squibb is bolstering its commercial cell therapy ambitions on the other side of the Atlantic. The company on Thursday pegged Leiden, Netherlands, as the home of its first cell therapy factory in Europe and its fifth worldwide. With planning for site design and… Read More »
News Consumer News Tecartus Approved for Treatment of Mantle Cell Lymphoma MONDAY, July 27, 2020 — Tecartus (brexucabtagene autoleucel) received approval for the treatment of mantle cell lymphoma (MCL) in patients who have not responded to other treatment types or relapsed following treatment, the U.S. Food and Drug Administration announced Friday. Tecartus is a chimeric… Read More »